The innate immunity and activation of the atherogenesis
- Authors: Tsygan V.N1, Bubnov V.A1, Tsygan N.V1, Zinovev E.V1, Ivchenko E.V1, Anichkov N.M1, Mirolyubov A.V1, Dergunov A.V1, Kazachenko A.I1
-
Affiliations:
- Issue: Vol 337, No 3 (2016)
- Pages: 47-54
- Section: Articles
- URL: https://journals.eco-vector.com/0026-9050/article/view/73560
- DOI: https://doi.org/10.17816/RMMJ73560
- ID: 73560
Cite item
Abstract
Full Text
About the authors
V. N Tsygan
V. A Bubnov
Email: bvamm@mail.ru
N. V Tsygan
E. V Zinovev
E. V Ivchenko
N. M Anichkov
A. V Mirolyubov
A. V Dergunov
A. I Kazachenko
References
- Anichkov N.N. Experimental arteriosclerosis in animals / Arteriosclerosis: A survey of the problem / Ed. by E.V.Cowdry. - New York: MacMillan Publishing, 1933. - P. 271-322.
- Anitschkow N., Chalatow S. Ueber experimentelle Cholester-insteatose und ihre Bedeutung fuer die Entstehung einiger pathologischer Prozesse // Zentrbl. Allg. Pathol. Pathol. Anat. - 1913. - Vol. 24. - P. 1-9.
- Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger // J. Leukoc. Biol. - 2007. - Vol. 81, N 1. - P. 1-5.
- Bjоrkbacka H., Kunjathoor V.V., Moore K.J. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways // Nat. Med. - 2004. - Vol. 10, N 4. - P. 416-421.
- Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis // Annu. Rev. Biochem. - 1983. - Vol. 52. - P. 223-261.
- Canton J., Neculai D., Grinstein S. Scavenger receptors in homeostasis and immunity // Nat. Rev. Immunol. - 2013. - Vol. 13, N 9. - P. 621-634.
- Cardiovascular diseases (CVDs). Factsheet N 317 // URL: http://www.who.int/mediacentre/factsheets/fs317/en/ (дата обращения: 6 июня 2015 г.).
- Chaudhury H., Zakkar M., Boyle J. et al. c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis // Arterioscler. Thromb. Vasc. Biol. - 2010. - Vol. 30, N 3. - P. 546-553.
- Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage // Nat. Rev. Immunol. - 2010. - Vol. 10, N 12. - P. 826-837.
- Dahlof B. Cardiovascular disease risk factors: epidemiology and risk assessment // Am. J. Cardiol. - 2010. - Vol. 105, Suppl. 1. - P. 3A-9A.
- Edfeldt K., Swedenborg J., Hansson G.K., Yan Z.Q. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation // Circulation. - 2002. - Vol. 105, N 10. - P. 1158-1161.
- Friedman M., Friedland G.W. Medicine’s 10 greatest discoveries. - New Haven, CT: Yale University Press, 1998. - 296 p.
- Gofman J.W., Lindgren F. The role of lipids and lipoproteins in atherosclerosis // Science. - 1950. - Vol. 111, N 2877. - P. 166-171.
- Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition // Proc. Natl. Acad. Sci. USA. - 1979. - Vol. 76, N 1. - P. 333-337.
- Greaves D.R., Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges // J. Lipid Res. - 2009. - Vol. 50, Suppl. - P. S282-S286.
- Hopkins P.N. Molecular Biology of Atherosclerosis // Physiol. Rev. - 2013. - Vol. 93, N 3. - P. 1317-1542.
- Hopkins P.N., Williams R.R. A survey of 246 suggested coronary risk factors // Atherosclerosis. - 1981. - Vol. 40, N 1. - P. 1-52.
- Kumar H., Kawai T., Akira S. Pathogen recognition by the innate immune system // Int. Rev. Immunol. - 2011. - Vol. 30, N 1. - P. 16-34.
- Kzhyshkowska J., Neyen C., Gordon S. Role of macrophage scavenger receptors in atherosclerosis // Immunobiology. - 2012. - Vol. 217, N 5. - P. 492-502.
- Marchetti P. Advanced glycation end products (AGEs) and their receptors (RAGEs) in diabetic vascular disease // Medicographia. - 2009. - Vol. 31, N 3. - P. 257-265.
- Mehta N.J., Khan I.A. Cardiology’s 10 greatest discoveries of the 20th century // Tex. Heart Inst. J. - 2002. - Vol. 29, N 3. - P. 164-171.
- Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake // Arterioscler. Thromb. Vasc. Biol. - 2006. - Vol. 26, N 8. - P. 1702-1711.
- Moore K.J., Kunjathoor V.V., Koehn S.L. et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice // J. Clin. Invest. - 2005. - Vol. 115, N 8. - P. 2192-2201.
- Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance // Nat. Rev. Immunol. - 2013. - Vol. 13, N 10. - P. 709-721.
- Prabhudas M., Bowdish D., Drickamer K. et al. Standardizing scavenger receptor nomenclature // J. Immunol. - 2014. - Vol. 192, N 5. - P. 1997-2006.
- Ross R. Atherosclerosis - an inflammatory disease // N. Engl. J. Med. - 1999. - Vol. 340, N 2. - P. 115-126.
- Stewart C.R., Stuart L.M., Wilkinson K. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer // Nat. Immunol. - 2010. - Vol. 11, N 2. - P. 155-161.
- Stoltz J.F., Muller S., Kadi A. et al. Introduction to endothelial cell biology // Clin. Hemorheol. Microcirc. - 2007. - Vol. 37, N 1-2. - P. 5-8.
- Sun B., Boyanovsky B.B., Connelly M.A. et al. Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI // J. Lipid Res. - 2007. - Vol. 48, N 12. - P. 2560-2570.
- Xu X.H., Shah P.K., Faure E. et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL // Circulation. - 2001. - Vol. 104, N 25. - P. 3103-3108.